levonorgestrel has been researched along with Endometrioma in 145 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.07) | 18.7374 |
| 1990's | 5 (3.45) | 18.2507 |
| 2000's | 52 (35.86) | 29.6817 |
| 2010's | 72 (49.66) | 24.3611 |
| 2020's | 13 (8.97) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, YC; Georgiou, EX; Gibbons, T; Wise, MR | 1 |
| Marquez, CM; Sadowski, EA; Schrager, S; Yogendran, L | 1 |
| Ambacher, K; Sanders, AP; Secter, M | 1 |
| Jung, SH; Jung, YW; Kim, HY; Lee, KH; Lee, M; Song, HJ; Song, SY; Yoo, HJ | 1 |
| Fenghua, Y; Guan, L; Juan, S; Rong, S | 1 |
| Dai, Y; Leng, JH; Li, XY; Shi, JH; Zhu, SY | 1 |
| Ma, R; Mao, H; Wang, L; Xu, H; Zhang, L; Zhao, R; Zheng, Y | 1 |
| Bahamondes, L; Carvalho, NM; Margatho, D | 1 |
| Abdelhakim, AM; Ahmed, SA; AlAmodi, AA; Ali, AS; Ashour, K; El Kattan, EAM; Elsherbini, M; Fathi, M; Haggag, H; Keshta, NHA; Salah, DM; Samy, A; Shareef, MA; Shatat, HBAE; Sileem, SA; Taher, A | 1 |
| Dai, Y; Gu, ZY; Jia, SZ; Leng, JH; Li, XY; Shi, JH; Wu, YS; Zhang, J; Zhu, SY | 1 |
| Agostini, A; Andriamanjay, D; Bourachot, M; Pivano, A; Siles, P | 1 |
| Benetti-Pinto, CL; Vitale, SG; Vizotto, MP; Yela, DA | 1 |
| Acién, M; Acién, P; Velasco, I | 1 |
| Álvarez, C; Jiménez, JS; Marqueta, L; Muñoz, JL; Simón, E; Tejerizo, Á | 1 |
| Cho, S; Choi, YS; Chon, SJ; Kim, MK; Lee, BS; Lee, JH; Seo, SK; Yun, BH | 1 |
| Ellett, L; Mooney, SS | 1 |
| Chang, X; Höchel, J; Klein, S; Müller, A; Nave, R | 1 |
| Qiu, H; Yuan, Z | 1 |
| Suzin, J; Szubert, M; Ziętara, M | 1 |
| Buggio, L; Frattaruolo, MP; Ottolini, F; Roberto, A; Somigliana, E; Vercellini, P | 1 |
| Baskent, E; Goynumer, G; Karamustafaoglu Balci, B; Yucel, N | 1 |
| Barra, F; Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL | 1 |
| Biggs, WS; Carey, ET; McIntyre, JM | 1 |
| Han, HY; Jung, YW; Kang, BH; Ko, YB; Lee, KH; Lee, M; Song, SY; Yang, JB; Yoo, HJ | 1 |
| Chen, L; Hu, J; Huang, Y; Wu, J; Zou, Y | 1 |
| Adachi, S; Enomoto, T; Ishiguro, T; Kitani, Y; Kobayashi, A; Nishikawa, N; Sekine, M; Tamura, R; Ueda, H | 1 |
| Chang, HK; Kwak, SM; Lee, GW; Lee, KH; Park, M; Song, SY; Yoo, HJ | 1 |
| Bahamondes, L; Eloy, L; Margatho, D; Mota Carvalho, N | 1 |
| Bahamondes, L; Benetti-Pinto, CL; Carvalho, N; Cursino, K; Margatho, D | 1 |
| Amat, L; Bulach, A; Leclercq, M; Mesrine, S; Scheffler, F; Scheffler, M; Sperandeo, D | 1 |
| Egekvist, AG; Forman, A; Graumann, O; Kesmodel, US; Marinovskij, E; Seyer-Hansen, M | 1 |
| Abou-Setta, AM; Al-Inany, HG; Farquhar, C; Houston, B | 1 |
| Hertweck, P; LaJoie, AS; Loveless, M; Yoost, J | 1 |
| Mocciaro, R; Morelli, M; Sacchinelli, A; Venturella, R; Zullo, F | 1 |
| Jianhong, Z; Lan, S; Lihui, W; Ling, L; Xijing, J | 1 |
| Munro, MG; Solnik, MJ | 1 |
| Avraham, S; Seidman, DS | 1 |
| Cho, S; Choi, YS; Jung, JA; Kim, HY; Lee, BS; Lee, JS; Lee, Y; Seo, SK | 1 |
| Bastianelli, C; Benagiano, G; Brosens, I; Farris, M | 1 |
| Altshuler, AL; Hillard, PJ | 1 |
| Brito, MB; Ferriani, RA; Garcia, AA; Rosa-e-Silva, JC; Vieira, CS; Yamaguti, EM | 1 |
| Brown, J; Farquhar, C | 1 |
| Arola, J; Fraser, IS; Heikinheimo, O; Manconi, F; Maneck, B; Mentula, M; Ng, CHM; Tarjanne, S | 1 |
| Drury, JA; Hapangama, DK; Mathew, D; Valentijn, AJ; Vasieva, O | 1 |
| Fukasawa, I; Hasegawa, K; Kawai, S; Kiuchi, K; Kosaka, N; Mochizuki, Y; Motegi, E | 1 |
| Barton, P; Bhattacharya, S; Horne, AW; Roberts, TE; Sanghera, S | 1 |
| Sarıdoğan, E | 1 |
| Cho, YJ; Jung, YW; Kim, MK; Kim, ML; Seong, SJ; Yun, BS | 1 |
| Klein, S; Kraetzschmar, J; Nave, R; Rautenberg, T; Rohde, B; Schmitz, H; Schultze-Mosgau, MH; Waellnitz, K | 1 |
| Bifulco, G; Biscione, A; Luisi, S; Morgante, G; Petraglia, F; Tosti, C | 1 |
| Chang, XY; Jia, SZ; Lang, YH; Leng, JH; Li, L; Li, XY; Liu, ZZ; Shi, JH; You, SS; Zhang, JJ | 1 |
| Benagiano, G; Bianchi, P; Brosens, I; Gordts, S; Guo, SW; Petraglia, F; Puttemans, P | 1 |
| Nave, R; Ploeger, BA; Reinecke, I; Schmitz, H; Schultze-Mosgau, MH | 1 |
| Chang, YH; Chen, YJ; Hsu, TF; Huang, BS; Tsai, HW; Wang, PH | 1 |
| Bhattacharya, S; Daniels, JP; Middleton, LJ; Weckesser, A | 1 |
| Bahamondes, L; Bahamondes, MV; Monteiro, I | 1 |
| de Paula Martins, W; de Sá Rosa e Silva, AC; Ferriani, RA; Manetta, LA; Nogueira, AA; Rosa e Silva, JC | 1 |
| Gold, MA; Johnson, LM | 1 |
| Kumar, U; Samuel, MI; Taylor, C; Tenant-Flowers, M | 1 |
| Abrão, MS; Bahamondes, L; Ferriani, RA; Hassan, D; Petta, CA; Podgaec, S; Rosa e Silva, JC | 2 |
| Lu, D; Sheng, J; Zhang, JP; Zhang, WY | 1 |
| Barbara, G; Somigliana, E; Vercellini, P; Vigano, P | 1 |
| Barbara, G; Berlanda, N; Crosignani, PG; Fedele, L; Somigliana, E; Vercellini, P | 1 |
| de Sá Rosa-e-Silva, AC; Ferriani, RA; Garcia, SB; Gomes, MK; Rosa-e-Silva, JC; Turatti, A; Vieira, CS | 1 |
| Cheng, B; Huang, Y; Xin, X; Yuan, P; Zhang, J | 1 |
| Huang, Y; Teng, Z; Wu, H; Xin, X; Yuan, P; Zhang, J | 1 |
| Kitawaki, J | 1 |
| Ferreira, RA; Ferriani, RA; Nogueira, AA; Rosa-e-Silva, AC; Rosa-E-Silva, JC; Vieira, CS | 1 |
| Gan, XQ; Ke, PQ; Wang, JH; Wang, NN; Zheng, QQ; Zheng, Z | 1 |
| Shimoni, N | 1 |
| Alhamdan, D; Bignardi, T; Condous, G; Hardas, G; Merkur, H | 1 |
| Härkki, P; Jokinen, JJ; Salo, JA; Sihvo, E | 1 |
| Guo, SW | 1 |
| Chin, RK; Tang, LC; Wong, AY | 1 |
| Chen, SU; Ho, HN; Peng, FS; Wu, MY; Yang, JH; Yang, YS | 1 |
| Cho, S; Choi, YS; Heena, K; Jeon, YE; Kim, HY; Lee, BS; Lee, KE; Lim, KJ; Seo, SK; Yang, HI | 1 |
| Altinbas, SK; Bayoglu Tekin, Y; Dilbaz, B; Dilbaz, S | 1 |
| Abedin, P; Balogun, M; Champaneria, R; Daniels, J; Khan, KS | 1 |
| Ahuja, SP; Hertweck, SP | 1 |
| Akgul, MA; Akyol, M; Haberal, A; Kaplan, M; Karcaaltincaba, M; Kayikcioglu, F; Ozdegirmenci, O | 1 |
| Brown, J; Hart, RJ; Pan, A | 1 |
| Gupta, SS; Mathur, RK; Shukla, S; Singh, O | 1 |
| Basu, A; Haran, M; Nair, A | 1 |
| Ferrero, S; Remorgida, V; Tramalloni, D; Venturini, PL | 1 |
| Emembolu, JO; Engemise, SL; Konje, JC; Taylor, AH; Willets, JM | 1 |
| Guan, YT; He, FF; Hu, Y; Lin, M; Sun, J; Wang, LD; Xu, XW; Zhang, YW | 1 |
| Guan, YT; Hu, Y; Wang, LD; Xu, XW; Yan, LZ; Zhu, SC; Zhu, XQ | 1 |
| Gemzell-Danielsson, K; Heikinheimo, O | 1 |
| Emembolu, JO; Engemise, SL; Konje, JC; Willets, JM | 1 |
| Forman, A; Kruse, C; Seyer-Hansen, M | 1 |
| Angsuwathana, S; Indhavivadhana, S; Leerasiri, P; Rattanachaiyanont, M; Tanmahasamut, P; Techatraisak, K | 1 |
| Chen, B; Huang, Y; Xin, X; Yuan, P | 1 |
| Koga, K; Osuga, Y; Takamura, M; Takemura, Y; Taketani, Y | 1 |
| Ikomi, A; Pepra, EF | 1 |
| Johansson, E; Laoag-Fernandez, JB; Maruo, T; Pakarinen, P; Spitz, IM | 1 |
| Aimi, G; Crosignani, PG; De Giorgi, O; Frontino, G; Vercellini, P; Zaina, B | 1 |
| Emembolu, JO; Konje, JC; Lockhat, FB | 2 |
| Athayde, C; Coelho, G; Coutinho, EM; Maia, H; Maltez, A | 1 |
| Berlanda, N; Fedele, L | 1 |
| Hurskainen, R; Paavonen, J | 1 |
| Emembolu, JE; Konje, JC; Lockhat, FB | 1 |
| Somigliana, E; Vercellini, P; Viganò, P | 1 |
| Athayde, C; Coutinho, EM; Maia, H; Maltez, A; Studart, E | 1 |
| Ibraheim, M; Ikomi, A | 1 |
| Han, YH; He, LH; He, SM; Wei, MX | 1 |
| McGavigan, CJ; Owen, P | 1 |
| Gupta, JK; Sinha, D; Varma, R | 1 |
| Brosens, I; Farquhar, C | 1 |
| Abrão, MS; de Sá Rosa e Silva, AC; Ferriani, RA; Nogueira, AA; Petta, CA; Rosa e Silva, JC | 1 |
| Rabinovici, J; Stewart, EA | 1 |
| Abou-Setta, AM; Al-Inany, HG; Farquhar, CM | 1 |
| Cui, GF; Lu, D; Sheng, J; Zhang, JP | 1 |
| Deng, S; Lang, JH; Leng, JH; Liu, ZF; Sun, DW; Zhu, L | 1 |
| He, SM; Zhang, YD | 1 |
| Cândido dos Reis, FJ; Ferriani, RA; Gomes, MK; Japur de Sá Rosa e Silva, AC; Rosa e Silva, JC; Vieira, CS | 1 |
| Hompes, PG; Mijatovic, V | 1 |
| Bahamondes, L; Fernandes, A; Monteiro, I; Petta, CA | 1 |
| Deng, S; Lang, JH; Leng, JH; Liu, ZF; Sun, DW; Tan, XJ; Zhu, L | 1 |
| Dai, Y; Deng, S; Lang, JH; Leng, JH; Liu, ZF; Sun, DW; Tan, XJ; Zhu, L | 1 |
| Mansour, D | 1 |
| Al-Jefout, M; Fraser, IS; Palmer, J | 1 |
| Hulsey, TC; Hulsey, TF; Roman, H | 1 |
| Bahamondes, L; Bragheto, AM; Caserta, N; Petta, CA | 1 |
| Bianchi, S; Fedele, L; Frontino, G | 1 |
| Luisi, S; Petraglia, F | 1 |
| Stekkinger, E; van der Linden, PJ | 1 |
| Higgins, M; Kelehan, P; O'Herlihy, C; Rizkalla, HF | 1 |
| Chay, D; Cho, DJ; Cho, S; Kim, H; Lee, B; Nam, A; Park, K; Park, Y | 1 |
| Panay, N | 1 |
| Harrison, GR; Khan, KS; Nawathe, A; Patwardhan, S; Yates, D | 1 |
| Jones, RC | 1 |
| Bianchi, S; Dorta, M; Fedele, L; Portuese, A; Raffaelli, R | 1 |
| Abulafia, O; Sherer, DM | 1 |
| Aimi, G; Crosignani, PG; De Giorgi, O; Panazza, S; Pesole, A; Vercellini, P | 1 |
| Fong, YF; Singh, K | 1 |
| Amundsen, CL; McGuire, EJ; Westney, OL | 1 |
| Bianchi, S; Fedele, L; Portuese, A; Raffaelli, R; Zanconato, G | 1 |
| Johansson, E; Laoag-Fernandez, JB; Maruo, T; Murakoshi, H; Pakarinen, P; Spitz, IM | 1 |
| Luukkainen, T; Pakarinen, P; Toivonen, J | 1 |
| Alvarez, F; Brache, V; Coutinho, E; Diaz, S; el Mahgoub, S; Mattos, CE; Pavez, M; Sivin, I; Stern, J; Thevenin, F | 1 |
| Collins, DC; Gould, KG; Kessler, MJ; Mann, DR; Smith, MM | 1 |
| Collins, DC; Gould, KG; Mann, DR; Schleicher, RL | 1 |
46 review(s) available for levonorgestrel and Endometrioma
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Topics: Dysmenorrhea; Endometriosis; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2021 |
The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review.
Topics: Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain; Progestins; Prospective Studies; Quality of Life | 2022 |
Efficacy and safety of different subsequent therapies after fertility preserving surgery for endometriosis: A systematic review and network meta-analysis.
Topics: Danazol; Endometriosis; Female; Gestrinone; Humans; Leuprolide; Levonorgestrel; Mifepristone; Network Meta-Analysis | 2023 |
Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
Topics: Contraceptive Agents, Hormonal; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Levonorgestrel; Nandrolone; Network Meta-Analysis; Pelvic Pain; Pyrimidines; Randomized Controlled Trials as Topic; Visual Analog Scale | 2021 |
Conservative treatment of deep infiltrating endometriosis: review of existing options.
Topics: Adult; Conservative Treatment; Contraceptives, Oral, Combined; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Minimally Invasive Surgical Procedures; Pain; Pain Management; Pain Measurement | 2018 |
Limited evidence guides empiric Tx of female chronic pelvic pain.
Topics: Adult; Amitriptyline; Analgesics; Chronic Pain; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Endometriosis; Evidence-Based Medicine; Female; Gabapentin; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Pain Management; Pain Measurement; Pelvic Pain; Physical Therapy Modalities | 2018 |
Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis.
Topics: Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; MEDLINE; Pain Management; Patient Satisfaction; Postoperative Care; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Secondary Prevention; Uterine Hemorrhage | 2018 |
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Topics: Contraceptive Agents, Female; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Postoperative Care; Secondary Prevention | 2013 |
Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
Topics: CA-125 Antigen; Cholesterol, LDL; Contraceptive Agents, Female; Databases, Bibliographic; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Membrane Proteins; Pain Measurement; Premenopause; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Indications and alternatives to hysterectomy.
Topics: Adenomyosis; Aromatase Inhibitors; Chronic Pain; Endometrial Hyperplasia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Pelvic Pain; Polyps; Uterine Artery Embolization; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2014 |
Selective progesterone receptor modulators: an update.
Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms | 2014 |
Menstrual suppression for adolescents.
Topics: Adolescent; Adolescent Health Services; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Pelvic Pain; Quality of Life; Treatment Outcome | 2014 |
An overview of treatments for endometriosis.
Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Pelvic Pain | 2015 |
Adolescent endometriosis.
Topics: Adolescent; Contraceptives, Oral, Combined; Disease Management; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain | 2017 |
Hormonal therapy for endometriosis: from molecular research to bedside.
Topics: Aromatase Inhibitors; Endometriosis; Female; Hormone Antagonists; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Selective Estrogen Receptor Modulators; Treatment Outcome | 2017 |
Pharmacologic treatment of the ovarian endometrioma.
Topics: Contraceptives, Oral; Desogestrel; Endometriosis; Female; Humans; Levonorgestrel | 2016 |
Levonorgestrel-releasing intrauterine system: uses and controversies.
Topics: Contraception; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Endometrium; Estrogen Replacement Therapy; Female; Genital Diseases, Female; HIV Infections; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Risk Assessment; Thrombophilia; Treatment Outcome; Uterine Neoplasms | 2008 |
Intrauterine devices and adolescents.
Topics: Adolescent; Contraceptive Agents; Endometriosis; Equipment Design; Female; Humans; Inflammation; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pregnancy; Pregnancy in Adolescence | 2008 |
Treatment of endometriosis-related pain: options and outcomes.
Topics: Denervation; Endometriosis; Female; Humans; Intrauterine Devices; Levonorgestrel; Mast Cells; Pelvic Pain; Pelvis; Progestins; Treatment Outcome | 2009 |
Medical treatment for rectovaginal endometriosis: what is the evidence?
Topics: Anastrozole; Aromatase Inhibitors; Cohort Studies; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Levonorgestrel; Nitriles; Pain; Patient Preference; Randomized Controlled Trials as Topic; Rectal Diseases; Treatment Outcome; Triazoles; Vaginal Diseases | 2009 |
[Maintenance therapy for endometriosis].
Topics: Clinical Trials as Topic; Contraceptives, Oral; Danazol; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Progesterone Congeners | 2010 |
Intrauterine contraceptives: a review of uses, side effects, and candidates.
Topics: Contraception, Postcoital; Delayed-Action Preparations; Endometriosis; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2010 |
Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy.
Topics: Endometriosis; Female; Humans; Levonorgestrel; Magnetic Resonance Imaging; Progesterone Congeners; Ultrasonography | 2010 |
Overview of bleeding disorders in adolescent females with menorrhagia.
Topics: Adolescent; Antifibrinolytic Agents; Blood Coagulation Disorders, Inherited; Contraceptives, Oral; Endometriosis; Female; Hemorrhagic Disorders; Hemostatics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ovarian Cysts | 2010 |
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.
Topics: Danazol; Drug Administration Routes; Dysmenorrhea; Dyspareunia; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Pain; Pelvic Pain; Randomized Controlled Trials as Topic | 2010 |
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Uterine Neoplasms | 2012 |
Diagnosis and treatment of rectovaginal endometriosis: an overview.
Topics: Administration, Intravaginal; Aromatase Inhibitors; Barium Sulfate; Colon; Constipation; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contrast Media; Danazol; Diagnostic Imaging; Dysmenorrhea; Dyspareunia; Endometriosis; Endoscopy, Digestive System; Enema; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Laparoscopy; Levonorgestrel; Pelvic Pain; Postoperative Complications; Progesterone Congeners; Rectal Diseases; Rectum; Vagina; Vaginal Diseases | 2012 |
Recurrence of endometrioma after laparoscopic excision and its prevention by medical management.
Topics: Contraceptives, Oral; Endometriosis; Female; Humans; Japan; Laparoscopy; Levonorgestrel; Logistic Models; Neoplasm Recurrence, Local; Risk Factors | 2013 |
Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities.
Topics: Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Progesterone Congeners; Uterine Diseases; Uterine Neoplasms | 2002 |
Emerging drugs for endometriosis.
Topics: Adult; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Contraceptives, Oral, Hormonal; Cytokines; Danazol; Endometriosis; Estradiol; Estrogen Receptor Modulators; Female; Gestrinone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormone Replacement Therapy; Humans; Infertility, Female; Levonorgestrel; Mifepristone; Ovary; Ovulation; Pregnancy; Progestins; Randomized Controlled Trials as Topic | 2004 |
Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2004 |
The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis.
Topics: Contraceptive Agents, Female; Dysmenorrhea; Dyspareunia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain; Progestins; Treatment Outcome | 2005 |
Treating endometriosis with the levonorgestrel-releasing intrauterine system: real hope or gimmick?
Topics: Contraceptive Agents, Female; Endometriosis; Female; Humans; Levonorgestrel | 2005 |
The levonorgestrel-releasing intrauterine system in modern gynaecology.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Premenstrual Syndrome; Uterine Hemorrhage; Uterine Neoplasms | 2005 |
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Topics: Delayed-Action Preparations; Dysmenorrhea; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2006 |
Medical and surgical management of adenomyosis.
Topics: Aromatase Inhibitors; Contraceptive Agents, Female; Danazol; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Uterine Diseases; Uterine Neoplasms | 2006 |
New interventional techniques for adenomyosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Danazol; Diagnosis, Differential; Embolization, Therapeutic; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Pregnancy; Uterine Diseases; Uterine Neoplasms | 2006 |
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Topics: Contraceptive Agents, Female; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Secondary Prevention | 2006 |
Endometriosis: the way forward.
Topics: Acyl Coenzyme A; Angiogenesis Inhibitors; Aromatase Inhibitors; Endometriosis; Female; Humans; Immunologic Factors; Laparoscopy; Levonorgestrel; Selective Estrogen Receptor Modulators | 2007 |
Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Topics: Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain; Progestins; Randomized Controlled Trials as Topic | 2007 |
Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Endometrial Hyperplasia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia | 2007 |
Hormonal treatments for adenomyosis.
Topics: Danazol; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Levonorgestrel | 2008 |
[A levonorgestrel-containing IUD for the treatment of endometriosis].
Topics: Contraceptive Agents, Female; Endometriosis; Evidence-Based Medicine; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain Management; Patient Compliance; Treatment Outcome | 2007 |
Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis.
Topics: Analgesics; Angiogenesis Inhibitors; Aromatase Inhibitors; Contraceptive Agents, Female; Endometriosis; Estrogen Antagonists; Female; Humans; Immunologic Factors; Levonorgestrel; Pelvic Pain; Quality of Life; Receptors, Progesterone | 2008 |
Angiogenesis of the endometrium.
Topics: Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Endometrium; Female; Humans; Leiomyoma; Levonorgestrel; Neovascularization, Physiologic | 1999 |
Therapeutic use of the LNG IUS, and counseling.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contraceptive Agents, Female; Counseling; Endometriosis; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Pregnancy; Premenstrual Syndrome | 2001 |
35 trial(s) available for levonorgestrel and Endometrioma
| Article | Year |
|---|---|
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
Topics: Adolescent; Adult; Brazil; CA-125 Antigen; Desogestrel; Drug Implants; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pain Measurement; Pelvic Pain; Young Adult | 2020 |
Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial.
Topics: Anastrozole; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; London; Prospective Studies | 2021 |
Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol-9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring.
Topics: Administration, Intravaginal; Adult; Anastrozole; Anti-Bacterial Agents; Antifungal Agents; Clindamycin; Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Levonorgestrel; Menstrual Hygiene Products; Miconazole; Nitriles; Nonoxynol; Triazoles | 2018 |
Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
Topics: Adult; Biomarkers; Brazil; CA-125 Antigen; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometriosis; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Nerve Fibers; Pelvic Pain; Receptors, IgE; Treatment Outcome | 2018 |
Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Liberation; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain Management; Pelvic Pain | 2018 |
Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: a randomized clinical trial.
Topics: Adolescent; Adult; Blood Coagulation; Contraceptive Agents, Female; Delayed-Action Preparations; Endometriosis; Female; Fertility Agents, Female; Hemostasis; Hemostatics; Humans; Leuprolide; Levonorgestrel; Treatment Outcome; Young Adult | 2014 |
Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial.
Topics: Administration, Intravaginal; Adult; Anastrozole; Aromatase Inhibitors; Endometriosis; Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Nitriles; Ovarian Follicle; Premenopause; Triazoles; Women's Health; Young Adult | 2016 |
Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.
Topics: Administration, Intravaginal; Adult; Anastrozole; Computer Simulation; Contraceptive Agents, Female; Drug Combinations; Drug Interactions; Endometriosis; Estradiol; Female; Humans; Levonorgestrel; Models, Biological; Nitriles; Ovarian Follicle; Sex Hormone-Binding Globulin; Triazoles; Young Adult | 2017 |
Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study.
Topics: Adult; CA-125 Antigen; Contraceptives, Oral, Synthetic; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Membrane Proteins; Neoplasm Recurrence, Local; Pelvic Pain; Postoperative Period; Prospective Studies; Recurrence; Treatment Outcome | 2017 |
Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitme
Topics: Adolescent; Adult; Clinical Protocols; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Endometriosis; Feasibility Studies; Female; Humans; Injections; Intrauterine Devices; Laparoscopy; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Patient Selection; Pilot Projects; Progestins; Recurrence; Research Design; Secondary Prevention; Time Factors; Treatment Outcome; United Kingdom; Young Adult | 2017 |
Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist.
Topics: Adolescent; Adult; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Pulsatile Flow; Ultrasonography; Uterine Diseases; Uterus; Young Adult | 2008 |
The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Dysmenorrhea; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction | 2009 |
Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.
Topics: Adolescent; Adult; Apoptosis; Cell Proliferation; Endometriosis; Endometrium; Estrogen Receptor alpha; fas Receptor; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Pain; Receptors, Progesterone | 2009 |
Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
Topics: Adult; Biomarkers; Cardiovascular System; Contraceptive Agents, Female; Endometriosis; Female; Homocysteine; Humans; Interleukin-6; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Pain; Pain Measurement; Prospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
Mirena intra-uterine system: does it improve long term symptoms in women with chronic pelvic pain and/or endometriosis after laparoscopy? A multicentre randomized controlled trial.
Topics: Adolescent; Adult; Chronic Disease; Contraceptive Agents, Female; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Middle Aged; Pain, Postoperative; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Young Adult | 2010 |
Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial.
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate | 2010 |
Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
Topics: Adult; Chronic Disease; Delayed-Action Preparations; Endometriosis; Female; Fertility Agents, Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Gynecologic Surgical Procedures; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain, Postoperative; Pelvic Pain; Treatment Outcome; Uterine Diseases | 2011 |
Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis.
Topics: Adult; Endometriosis; Female; Fertility Agents, Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Quality of Life; Treatment Outcome; Uterine Diseases | 2011 |
Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Biopsy; Down-Regulation; Drug Delivery Systems; Endometriosis; Endometrium; Female; Follicular Phase; Humans; Immunohistochemistry; Levonorgestrel; Luteal Phase; Protein Isoforms; Receptors, Estrogen; Receptors, Progesterone; Severity of Illness Index; Young Adult | 2011 |
[Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
Topics: Adult; Combined Modality Therapy; Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Levonorgestrel; Ovarian Cysts; Recurrence; Treatment Outcome | 2011 |
The effect of the levonorgestrel-releasing intrauterine system, Mirena® on mast cell numbers in women with endometriosis undergoing symptomatic treatment.
Topics: Adolescent; Adult; Biopsy; Cell Count; Contraceptive Agents, Female; Endometriosis; Endometrium; Female; Follicular Phase; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteal Phase; Mast Cells; Receptors, Estrogen; Receptors, Progesterone; Severity of Illness Index; Young Adult | 2011 |
Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Double-Blind Method; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Pelvic Pain; Quality of Life; Severity of Illness Index | 2012 |
Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis.
Topics: Adrenomedullin; Adult; Contraceptive Agents, Female; Endometriosis; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Peptides; Time Factors; Vascular Endothelial Growth Factor A | 2003 |
Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study.
Topics: Adult; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Satisfaction; Pilot Projects; Postoperative Care; Progesterone Congeners; Secondary Prevention | 2003 |
Insertion of mirena after endometrial resection in patients with adenomyosis.
Topics: Adult; Contraceptives, Oral; Endometriosis; Endometrium; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Retrospective Studies; Treatment Outcome | 2003 |
The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.
Topics: Adult; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain Measurement; Pelvic Pain; Progestins; Treatment Outcome | 2005 |
Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel.
Topics: Adult; Ascitic Fluid; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices; Levonorgestrel; Patient Satisfaction; Prospective Studies; Treatment Outcome | 2005 |
Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Topics: Adolescent; Adult; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Pelvic Pain | 2005 |
The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.
Topics: Adolescent; Adult; CA-125 Antigen; Contraceptive Agents, Female; Endometriosis; Equipment Failure Analysis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Outcome | 2006 |
[Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
Topics: Adult; Biomarkers; CA-125 Antigen; Contraceptive Agents, Female; Dysmenorrhea; Endometriosis; Estradiol; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pain Measurement; Pelvic Pain; Treatment Outcome; Uterus | 2006 |
[Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Outcome | 2006 |
The levonorgestrel-releasing intrauterine system and endometriosis staging.
Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain | 2007 |
Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
Topics: Adult; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Organ Size; Pain Measurement; Treatment Outcome; Uterus | 2008 |
Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis.
Topics: Adult; Dysmenorrhea; Dyspareunia; Endometriosis; Female; Humans; Intrauterine Devices; Levonorgestrel; Pain; Pelvic Pain; Prospective Studies; Rectal Diseases; Ultrasonography; Vaginal Diseases | 2001 |
Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
Topics: Adolescent; Adult; Endometriosis; Female; Hemoglobins; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menstruation Disturbances; Patient Dropouts; Pelvic Inflammatory Disease | 1991 |
64 other study(ies) available for levonorgestrel and Endometrioma
| Article | Year |
|---|---|
Adenomyosis: Diagnosis and Management.
Topics: Adenomyosis; Adult; Contraceptive Agents, Hormonal; Endometriosis; Female; Humans; Hysterectomy; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Menorrhagia; Middle Aged; Pelvic Pain; Pregnancy; Risk Factors; Ultrasonography | 2022 |
Long-term efficacy and safety of levonorgestrel-releasing intrauterine system as a maintenance treatment for endometriosis.
Topics: Contraceptives, Oral, Combined; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain; Retrospective Studies | 2022 |
Effect of Mirena intrauterine device combined with GNRH-A on endometriosis, sex hormone level and carbohydrate antigen 125.
Topics: CA-125 Antigen; Carbohydrates; Coitus; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Levonorgestrel; Pain | 2022 |
The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
Topics: Adenomyosis; Case-Control Studies; Dysmenorrhea; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Retrospective Studies | 2023 |
Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion.
Topics: Adult; Combined Modality Therapy; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Postoperative Period; Secondary Prevention; Treatment Outcome | 2021 |
Medical management of psoas muscle deep endometriosis: A case report.
Topics: Adult; Contraceptive Agents, Female; Cytochrome P-450 CYP1A1; Endometriosis; Female; Humans; Levonorgestrel; Psoas Muscles; Steroid Hydroxylases | 2021 |
Risk factors for recurrence of deep infiltrating endometriosis after surgical treatment.
Topics: Adult; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Retrospective Studies; Risk Factors | 2021 |
Conservative management in ureteric hydronephrosis due to deep endometriosis: Could the levonorgestrel-intrauterine device be an option?
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Gynecologic Surgical Procedures; Humans; Hydronephrosis; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Stents; Ureteral Diseases | 2017 |
Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study.
Topics: Adult; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Recurrence; Secondary Prevention; Treatment Outcome | 2018 |
Umbilical endometriosis: a potential encounter for general surgeons.
Topics: Adult; Endometriosis; Female; Humans; Intrauterine Devices; Laparoscopy; Levonorgestrel; Peritoneal Diseases; Surgeons; Treatment Outcome; Umbilicus | 2019 |
Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study.
Topics: Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local | 2017 |
Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2018 |
The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis.
Topics: Adult; CA-125 Antigen; Chronic Pain; Contraceptive Agents, Female; Cross-Sectional Studies; Dysmenorrhea; Dyspareunia; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Membrane Proteins; Middle Aged; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Surveys and Questionnaires; Young Adult | 2018 |
Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Incidence; Intention to Treat Analysis; Intestinal Diseases; Italy; Levonorgestrel; Metrorrhagia; Norethindrone; Norethindrone Acetate; Ovarian Diseases; Pain Measurement; Patient Dropouts; Patient Preference; Pelvic Pain; Prospective Studies; Vaginal Diseases | 2018 |
Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Pain, Postoperative; Pelvic Pain; Young Adult | 2018 |
Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Topics: Adenomyosis; Adult; China; Desogestrel; Dysmenorrhea; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Levonorgestrel; Luteinizing Hormone; Middle Aged; Uterus | 2018 |
Ectopic pregnancy following oral levonorgestrel emergency contraception use.
Topics: Adult; Contraception, Postcoital; Contraceptive Agents, Female; Endometriosis; Female; Humans; Levonorgestrel; Pregnancy; Pregnancy, Ectopic | 2019 |
[Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].
Topics: Administration, Cutaneous; Administration, Intravaginal; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ovarian Cysts; Ovarian Neoplasms; Pregnancy | 2018 |
Conservative treatment of rectosigmoid endometriosis: A prospective study.
Topics: Administration, Oral; Adult; Conservative Treatment; Contraceptives, Oral; Denmark; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Rectal Diseases; Sigmoid Diseases; Surveys and Questionnaires | 2019 |
Use of the levonorgestrel intrauterine system in adolescents with endometriosis.
Topics: Adolescent; Adult; Cohort Studies; Combined Modality Therapy; Contraceptive Agents, Female; Drug Therapy, Combination; Endometriosis; Female; Follow-Up Studies; Hemorrhage; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
Topics: Adult; Combined Modality Therapy; Contraceptive Agents, Female; Drug Combinations; Endometriosis; Estradiol; Estrogens; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Nandrolone; Patient Satisfaction; Pelvic Pain; Postoperative Care; Receptors, Progesterone; Retrospective Studies; Secondary Prevention | 2013 |
Surgery versus pharmacological treatment for endometriosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Nandrolone; Pelvic Pain; Progestins | 2014 |
Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence.
Topics: Adult; Contraceptives, Oral, Hormonal; Disease-Free Survival; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Middle Aged; Retrospective Studies; Secondary Prevention | 2014 |
Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis.
Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Immunohistochemistry; Levonorgestrel; Nerve Fibers, Unmyelinated; Nerve Growth Factor; Progesterone Congeners; Receptor Protein-Tyrosine Kinases; Rectal Diseases; Vaginal Diseases; Young Adult | 2015 |
In silico, in vitro and in vivo analysis identifies a potential role for steroid hormone regulation of FOXD3 in endometriosis-associated genes.
Topics: Adolescent; Adult; Biopsy; Blotting, Western; Computational Biology; Computer Simulation; Embryo Implantation; Endometriosis; Endometrium; Epithelial Cells; Female; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Immunohistochemistry; Levonorgestrel; Middle Aged; Oligonucleotide Array Sequence Analysis; Progesterone; RNA, Messenger; Stromal Cells; Uterine Diseases; Young Adult | 2016 |
Levonorgestrel-releasing intrauterine system placement for severe uterine cervical stenosis after conization: two case reports.
Topics: Adult; Conization; Constriction, Pathologic; Contraceptive Agents, Female; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Quality of Life; Severity of Illness Index; Treatment Outcome | 2016 |
Pharmaceutical treatments to prevent recurrence of endometriosis following surgery: a model-based economic evaluation.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Models, Economic; Primary Health Care; Quality-Adjusted Life Years; Secondary Prevention; Tranexamic Acid; Treatment Outcome | 2016 |
The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
Topics: Adult; Combined Modality Therapy; Contraceptives, Oral, Combined; Drug Administration Schedule; Endometriosis; Female; Humans; Levonorgestrel; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
[A prospective cohort study on the impact of placement timing of LNG-IUS for adenomyosis].
Topics: Adenomyosis; Adult; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Young Adult | 2016 |
Two for the price of one.
Topics: Adult; Anemia; Anti-HIV Agents; Contraceptive Agents, Female; Drug Therapy, Combination; Endometriosis; Female; HIV Seropositivity; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Nevirapine; Reverse Transcriptase Inhibitors; Treatment Outcome | 2008 |
A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Pain Measurement; Pelvic Pain; Treatment Outcome; Young Adult | 2009 |
Induction of a local pseudo-pregnancy for the treatment of endometriosis.
Topics: Adult; Biocompatible Materials; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Microspheres; Models, Biological; Models, Theoretical; Polymers; Pseudopregnancy; Treatment Outcome | 2010 |
Induction of a local pseudo-pregnancy via levonorgestrel-loaded microspheres for the treatment of endometriosis in a rabbit model.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Endometriosis; Female; Levonorgestrel; Microspheres; Pregnancy; Pseudopregnancy; Rabbits | 2010 |
ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives.
Topics: Acne Vulgaris; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Genital Diseases, Female; Hirsutism; Humans; Leiomyoma; Levonorgestrel; Menstruation; Ovarian Cysts; Premenstrual Syndrome; Uterine Neoplasms | 2010 |
[Effect of levonorgestrel-releasing intrauterine system combined with GnRH analogue for treatment of large adenomyosis].
Topics: Adult; Delayed-Action Preparations; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Uterine Diseases | 2010 |
Menstruation-related spontaneous pneumothorax and diaphragmatic endometriosis.
Topics: Adult; Contraceptives, Oral, Synthetic; Diaphragm; Endometriosis; Female; Humans; Levonorgestrel; Menstruation; Pleura; Pneumothorax; Progestins; Thoracic Diseases; Thoracotomy | 2010 |
Valproic acid as a therapy for adenomyosis: a comparative case series.
Topics: Adult; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Organ Size; Pain Measurement; Random Allocation; Uterus; Valproic Acid | 2010 |
Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method.
Topics: Adult; Anemia; Contraceptive Agents, Female; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Retrospective Studies; Uterine Diseases | 2010 |
Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis.
Topics: Adult; Dysmenorrhea; Endometriosis; Female; Fluorescent Antibody Technique; Humans; Levonorgestrel; Middle Aged; Nerve Growth Factor; Receptors, Nerve Growth Factor | 2010 |
Rare case of ureteral endometriosis presenting as hydronephrotic kidney.
Topics: Adult; Endometriosis; Female; Humans; Hydronephrosis; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Stents; Treatment Outcome; Ureteral Diseases; Ureteral Obstruction; Ureteroscopy; Urography | 2011 |
Letter in response to Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised trial by Wong AYK, Tang LC
Topics: Contraceptive Agents, Female; Endometriosis; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Severity of Illness Index | 2011 |
Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device.
Topics: Administration, Intravaginal; Adult; Contraceptive Agents, Female; Danazol; Endometriosis; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Patient Satisfaction; Pilot Projects; Rectal Diseases; Severity of Illness Index; Treatment Outcome; Vaginal Diseases | 2011 |
[Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
Topics: Adult; CA-125 Antigen; Delayed-Action Preparations; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Membrane Proteins; Ovarian Cysts; Pain Measurement; Pelvic Pain; Recurrence; Treatment Outcome | 2011 |
Long-term regression of experimental endometriosis in a rat model treated with local application of levonorgestrel-loaded biodegradable microspheres.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Body Weight; Disease Models, Animal; Endometriosis; Female; Humans; Levonorgestrel; Microspheres; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Treatment Outcome | 2012 |
The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease.
Topics: Adult; Cohort Studies; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Palliative Care; Progestins; Severity of Illness Index; Treatment Outcome | 2004 |
Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis.
Topics: Adult; Apoptosis; Cell Division; Contraceptives, Oral; Endometriosis; Female; Follicular Phase; Humans; Immunohistochemistry; Ki-67 Antigen; Levonorgestrel; Luteal Phase; Menstrual Cycle; Middle Aged; Ovulation; Paraffin; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Tissue Embedding | 2005 |
[Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis].
Topics: Adult; Endometriosis; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Outcome; Uterus | 2005 |
[Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Topics: Adult; Delayed-Action Preparations; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Pelvic Pain; Secondary Prevention; Treatment Outcome; Uterine Diseases | 2006 |
[Effects of medical treatment on apoptosis in eutopic endometrium of patients with endometriosis].
Topics: Apoptosis; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone | 2007 |
[Effects of progesterone and progestin on expression of regulated on activation, normal T cell expressed and secreted in eutopic endometrium from patients with endometriosis].
Topics: Cells, Cultured; Chemokine CCL5; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Progesterone; Progestins; Transforming Growth Factor alpha | 2007 |
Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis.
Topics: Adolescent; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain | 2007 |
How much confidence to place in a negative result?
Topics: Endometriosis; Female; Humans; Levonorgestrel; Reproducibility of Results; Treatment Outcome | 2007 |
Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging.
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Magnetic Resonance Imaging; Middle Aged; Uterine Diseases; Uterus | 2007 |
Local drug release systems in endometriosis.
Topics: Administration, Intravaginal; Danazol; Endometriosis; Estrogen Antagonists; Female; Humans; Levonorgestrel; Uterus | 2007 |
Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Topics: Endometrial Hyperplasia; Endometriosis; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Retrospective Studies; Treatment Failure; Uterine Neoplasms; Uterus | 2008 |
Advances in the medical management of endometriosis.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aromatase Inhibitors; Contraceptives, Oral; Endometriosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Levonorgestrel; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Steroids | 2008 |
The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat.
Topics: Animals; Castration; Contraceptives, Oral, Combined; Danazol; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Models, Biological; Norgestrel; Peritoneal Cavity; Pregnadienes; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Topics: Adult; Endometriosis; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Prospective Studies | 1997 |
A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study.
Topics: Adult; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstrual Cycle; Patient Satisfaction; Pilot Projects; Prospective Studies; Uterus | 1999 |
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Topics: Adult; Contraindications; Drug Implants; Endometriosis; Female; Humans; Hysterectomy; Levonorgestrel; Malignant Hyperthermia; Menorrhagia; Progesterone Congeners; Uterine Hemorrhage; Uterus | 1999 |
Bladder endometriosis: conservative management.
Topics: Adult; Aged; Cystoscopy; Endometriosis; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Progesterone Congeners; Urinary Bladder Diseases | 2000 |
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium.
Topics: Adult; Apoptosis; Cell Division; Drug Delivery Systems; Endometriosis; Endometrium; fas Receptor; Female; Humans; Levonorgestrel; Menorrhagia; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Time Factors | 2001 |
Treatment of endometriosis in monkeys: effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid.
Topics: Animals; Disease Models, Animal; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Infusion Pumps; Levonorgestrel; Luteinizing Hormone; Macaca mulatta; Menstrual Cycle; Monkey Diseases; Norgestrel; Progesterone | 1986 |
Serum levels of cholesterol and lipoproteins in rhesus monkeys: comparison of the effect of gonadotropin-releasing hormone agonist and the progestin, levonorgestrel.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Endometriosis; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Lipoproteins; Lipoproteins, VLDL; Macaca mulatta; Norgestrel; Uterine Neoplasms | 1987 |